Class IOngoingVoluntary: Firm initiated
ZMB Enterprises: food recall H-1263-2026
ZMB Enterprises of Carlsbad, CA recalled Addall XR Shot 1 single bottle, 2 fl. oz., liquid dietary supplement. Reason: The product contains 1,4-DMAA, Phenylethylamine and Phenibut. The FDA listed it as Class I in its Enforcement Report dated Sep 2, 2026.
Record status as published: Ongoing. openFDA data last updated Oct 21, 2026.
Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.
Recall details
- Product
- Addall XR Shot 1 single bottle, 2 fl. oz., liquid dietary supplement
- Product quantity
- unknown
- Reason for recall
- The product contains 1,4-DMAA, Phenylethylamine and Phenibut.
- Codes, lots and dates on the package
- Sold between July - December 2025
- Distribution pattern
- The firm markets their products online via their website addallxr.com
- Recalling firm
- ZMB Enterprises, Carlsbad, CA
- Classification
- Class I — the FDA uses this class for a situation in which there is a reasonable probability that using or being exposed to the product will cause serious adverse health consequences or death.
- Voluntary or mandated
- Voluntary: Firm initiated
- How the firm first notified customers
- Press Release
Advertisement
Dates
| Event | Date |
|---|---|
| Recall initiated by the firm | Apr 3, 2026 |
| Classified by the FDA | Aug 24, 2026 |
| Published in the Enforcement Report | Sep 2, 2026 |
Advertisement
OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.
Sources
- U.S. Food and Drug Administration, openFDA food enforcement reports, recall number H-1263-2026 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
- Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.